Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 51, 2022 - Issue 5
Open access
2,523
Views
4
CrossRef citations to date
0
Altmetric
Research Article
Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma
Shu Ichimiyaa Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;b Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
https://orcid.org/0000-0002-8184-615XView further author information
Akiko Fujimuraa Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;c Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanView further author information
, Muneyuki Masudad Department of Head and Neck Surgery, National Hospital Organization Kyushu Cancer Center, Fukuoka, JapanView further author information
, Shogo Masudaa Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;c Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanView further author information
, Ryuji Yasumatsuc Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
https://orcid.org/0000-0001-6199-0341View further author information
Masayo Umebayashie Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, JapanView further author information
, Hiroto Tanakae Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, JapanView further author information
, Norihiro Koyae Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, JapanView further author information
, Shinichiro Nakagawae Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, JapanView further author information
, Poh Yin Yewf R&D Department, Cancer Precision Medicine Inc, Kanagawa, JapanView further author information
, Sachiko Yoshimuraf R&D Department, Cancer Precision Medicine Inc, Kanagawa, JapanView further author information
, Hideya Onishia Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanView further author information
, Masafumi Nakamurab Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanView further author information
, Yusuke Nakamurag Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, JapanView further author information
& Takashi Morisakie Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, JapanCorrespondence[email protected]
View further author information
show allView further author information
Pages 1498-1514
|
Published online: 05 Sep 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.